Effect of Vaccination on Household Transmission of SARS-CoV-2 in England.
作者信息
Harris Ross J, Hall Jennifer A, Zaidi Asad, Andrews Nick J, Dunbar J Kevin, Dabrera Gavin
机构信息
Public Health England, London, United Kingdom
University College London Institute for Women's Health, London, United Kingdom.
出版信息
N Engl J Med. 2021 Aug 19;385(8):759-760. doi: 10.1056/NEJMc2107717. Epub 2021 Jun 23.
Abstract
摘要
相似文献
1
Effect of Vaccination on Household Transmission of SARS-CoV-2 in England.
N Engl J Med. 2021 Aug 19;385(8):759-760. doi: 10.1056/NEJMc2107717. Epub 2021 Jun 23.
2
Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants.
N Engl J Med. 2022 Feb 24;386(8):744-756. doi: 10.1056/NEJMoa2116597. Epub 2022 Jan 5.
3
Effect of Inactivated SARS-CoV-2 Vaccines and ChAdOx1 nCoV-19 Vaccination to Prevent COVID-19 in Thai Households (VacPrevent trial).
Int J Infect Dis. 2022 Nov;124:190-198. doi: 10.1016/j.ijid.2022.09.032. Epub 2022 Sep 28.
4
Comparative effectiveness of BNT162b2 and ChAdOx1 nCoV-19 vaccines against COVID-19.
BMC Med. 2023 Feb 28;21(1):78. doi: 10.1186/s12916-023-02795-w.
5
Evaluation of Humoral Immune Response after SARS-CoV-2 Vaccination Using Two Binding Antibody Assays and a Neutralizing Antibody Assay.
Microbiol Spectr. 2021 Dec 22;9(3):e0120221. doi: 10.1128/Spectrum.01202-21. Epub 2021 Nov 24.
6
Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD.
Gut. 2021 Oct;70(10):1884-1893. doi: 10.1136/gutjnl-2021-324789. Epub 2021 Apr 26.
7
Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial.
EBioMedicine. 2022 Nov;85:104298. doi: 10.1016/j.ebiom.2022.104298. Epub 2022 Oct 10.
8
Thrombocytopenia after COVID-19 vaccination.
J Autoimmun. 2021 Sep;123:102712. doi: 10.1016/j.jaut.2021.102712. Epub 2021 Jul 27.
9
MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature.
J Neurol. 2022 Oct;269(10):5198-5212. doi: 10.1007/s00415-022-11194-9. Epub 2022 Jun 23.
10
Association of COVID-19 vaccines ChAdOx1 and BNT162b2 with major venous, arterial, or thrombocytopenic events: A population-based cohort study of 46 million adults in England.
PLoS Med. 2022 Feb 22;19(2):e1003926. doi: 10.1371/journal.pmed.1003926. eCollection 2022 Feb.
引用本文的文献
1
Predicting antibody kinetics and duration of protection against SARS-CoV-2 following vaccination from sparse serological data.
PLoS Comput Biol. 2025 Jun 18;21(6):e1013192. doi: 10.1371/journal.pcbi.1013192. eCollection 2025 Jun.
2
Covid-19 in hospitals: Studying influencing factors through agent-based modelling.
PLoS One. 2025 Jun 18;20(6):e0326350. doi: 10.1371/journal.pone.0326350. eCollection 2025.
3
Unraveling Rising Mortality: Statistical Insights from Japan and International Comparisons.
Healthcare (Basel). 2025 May 30;13(11):1305. doi: 10.3390/healthcare13111305.
4
Phylogeographic and genetic network assessment of COVID-19 mitigation protocols on SARS-CoV-2 transmission in university campus residences.
EBioMedicine. 2025 Jun;116:105729. doi: 10.1016/j.ebiom.2025.105729. Epub 2025 May 9.
5
How do large-scale population studies inform vaccine evaluations in England?
Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxaf006.
6
Assessing favipiravir impact on SARS-CoV-2 transmission within households: Insights from a multi-center study (FaviPrev).
J Virus Erad. 2024 Dec 12;10(4):100576. doi: 10.1016/j.jve.2024.100576. eCollection 2024 Dec.
7
State-space modelling using wastewater virus and epidemiological data to estimate reported COVID-19 cases and the potential infection numbers.
J R Soc Interface. 2025 Jan;22(222):20240456. doi: 10.1098/rsif.2024.0456. Epub 2025 Jan 8.
8
Tracking vaccine effectiveness in an evolving pandemic, countering misleading hot takes and epidemiologic fallacies.
Am J Epidemiol. 2025 Apr 8;194(4):898-907. doi: 10.1093/aje/kwae280.
9
Mucosal immunization with ChAd-SARS-CoV-2-S prevents sequential transmission of SARS-CoV-2 to unvaccinated hamsters.
Sci Adv. 2024 Aug 2;10(31):eadp1290. doi: 10.1126/sciadv.adp1290. Epub 2024 Jul 31.
10
Comparative analysis of clinical characteristics of COVID-19 among vaccinated and unvaccinated patients in a major treatment facility in Ghana.
Ghana Med J. 2023 Dec;57(4):293-299. doi: 10.4314/gmj.v57i4.6.
本文引用的文献
1
HOSTED-England's Household Transmission Evaluation Dataset: preliminary findings from a novel passive surveillance system of COVID-19.
Int J Epidemiol. 2021 Jul 9;50(3):743-752. doi: 10.1093/ije/dyab057.
2
Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine.
Nat Med. 2021 May;27(5):790-792. doi: 10.1038/s41591-021-01316-7. Epub 2021 Mar 29.
3
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
Zotero 插件